Helicobacter pylori eradication improves glycemic control in type 2 diabetes patients with asymptomatic active Helicobacter pylori infection - Cheng, Kai‐Pi; Yang, Yao‐Jong; Hung, Hao‐Chang; Lin, Ching‐Han; Wu, Chung‐Tai; Hung, Mei‐Hui; Sheu, Bor‐Shyang; Ou, Horng‐Yih (Journal of diabetes investigation, 2019)
Keywords: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents - therapeutic use; Antidiabetics; Biomarkers - analysis; Blood glucose; Blood Glucose - analysis; Blood pressure; Cholesterol; Cross-Sectional Studies; Diabetes; Diabetes mellitus; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - epidemiology; Diabetes Mellitus, Type 2 - microbiology; Drug Therapy, Combination; Drugs; Female; Follow-Up Studies; Gastric cancer; Glycated Hemoglobin A - analysis; Glycemic control; Glycemic Index; Helicobacter eradication; Helicobacter Infections - complications; Helicobacter Infections - drug therapy; Helicobacter Infections - microbiology; Helicobacter pylori; Helicobacter pylori - drug effects; Hemoglobin; Hospitals; Humans; Hyperglycemia; Hyperglycemia - etiology; Hyperglycemia - pathology; Hyperglycemia - prevention & control; Hypoglycemia - etiology; Hypoglycemia - pathology; Hypoglycemia - prevention & control; Hypoglycemic Agents - therapeutic use; Immunoglobulin G; Immunoglobulins; Infections; Inflammation; Insulin; Insulin resistance; Male; Middle Aged; Original; Prognosis; Serology; Studies; Sulfonylurea; Urea; Young Adult; Glycemic control; Diabetes; Helicobacter eradication